- Home
- OPFI vs XBIT Comparison
OPFI vs XBIT Comparison
Compare OPFI & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPFI | XBIT |
|---|---|---|
| Founded | 2009 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.7M | 73.2M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | OPFI | XBIT |
|---|---|---|
| Price | $11.12 | $2.47 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 520.3K | 57.7K |
| Earning Date | 10-29-2025 | 11-12-2025 |
| Dividend Yield | ★ 2.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $335,423,000.00 | N/A |
| Revenue This Year | $120.32 | N/A |
| Revenue Next Year | $10.85 | N/A |
| P/E Ratio | $81.13 | ★ N/A |
| Revenue Growth | ★ 28.69 | N/A |
| 52 Week Low | $6.81 | $2.09 |
| 52 Week High | $17.73 | $4.67 |
Technical Indicators
Market Signals| Indicator | OPFI | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 58.80 | 49.62 |
| Support Level | $10.62 | $2.40 |
| Resistance Level | $11.69 | $2.55 |
| Average True Range (ATR) | 0.45 | 0.11 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 63.61 | 20.00 |
Price Performance
Historical ComparisonAbout OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.